Postoperative Same Day Closure of Giant Macular Hole With Silicone Oil

NCT ID: NCT06915948

Last Updated: 2025-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with stage 3 and 4 macular holes of size \>700 microns who underwent pars plana vitrectomy, Internal limiting Membrane peeling and silicone oil tamponade were followed at day 1 , 2 weeks and 1 month post silicone oil removal and anatomical closure of macular hole assessed at all intervals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients who attended Retina OPD in Ahalia Foundation Eye Hospital, Palakkad were selected to participate in the study

Basic demographic profile which includes name, age, gender , address was noted .

Structured questionnaire was used to collect information about the presence of any systemic risk factors like diabetes mellitus, hypertension, any prior retinal surgery and high myopia .

Preoperatively , all subjects will be tested for BCVA , intraocular pressure measurement, slit lamp bio-microscopy of anterior segment and indirect non contact bio-microscopy of the fundus with 20D lens will be documented .

Using spectral domain optical coherence tomography diagnosis of macular hole was confirmed and hole form factor and diameter hole index calculated based on the findings in optical coherence tomography.

Patients with stage 3 and 4 macular holes of size \>700 u who underwent pars plana vitrectomy, ILM peeling and silicone oil tamponade were shortlisted.

Patients follow up was done on day 1, 2 weeks and 1 month post silicone oil removal .

For each follow up , BCVA with silicon oil and intraocular pressure was measured and indirect noncontact bio-microscopy examination of the macula was examined. Assessment of macula was done using OCT on day 1, 2 weeks and 1 month post silicone oil removal .

In all patients the anatomical closure of macular hole was assessed on day 1, 2 weeks and 1 month post silicone oil removal .

Statistical methods

* The information recorded on the data collection forms were uploaded in an excel sheet and data were analyzed using IBM SPSS version 20.
* To obtain the characteristic of categorical variables, frequency and percentage were applied.
* To obtain the characteristic of numerical variables, mean and standard deviation were used.
* Chi square test/ Fisher's exact test was used to find association between HFF, DHI, gender with hole closure type of closure.
* Students t test and Man Whitney U test were performed to compare the average values of numerical parameters such as age, BCVA with hole closure, type of closure, HFF, DHI.
* Paired t test was used to compare the pre-Op and Final BCVA. P-value \<0.05 was consideredto denote statistical significance.
* ANOVA was used wherever we had to compare numerical data/means between 3 groups of type of hole closure- open vs type I vs type II closure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Macular Holes Vitrectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Macular Hole Surgery

Pars Plana Vitrectomy with ILM peeling with silicone oil tamponade

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with idiopathic chronic giant macular hole more than 700 micron size confirmed by indirect biomicroscopy and optical coherence tomography.
* Patients who give a valid informed consent
* Patients who underwent surgery

Exclusion Criteria

* High myopic patients ( \>10 D)
* Patients with history of ocular trauma
* Patients with history of any macular surgery
* Rhegmatogenous retinal detachment associated with macular hole
* Patients having vision loss due to other ocular comorbidities- glaucoma , macular pathology or vitreous hemorrhage.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ahalia Foundation Eye Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Saurav Mahajan

Principal Investigator, Clinical Professor Adjunct

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rajkumar Maheshwari, MS

Role: PRINCIPAL_INVESTIGATOR

Ahalia Foundation Eye Hospital

Amrutha S, DNB

Role: PRINCIPAL_INVESTIGATOR

Ahalia Foundation Eye Hospital

Saurav Mahajan, MS

Role: PRINCIPAL_INVESTIGATOR

Ahalia Foundation Eye Hospital

Sajeev C Jacob, MS

Role: STUDY_CHAIR

Ahalia Foundation Eye Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ahaliafoundation Eye Hospital

Palakkad, Kerala, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1312-4425

Identifier Type: OTHER

Identifier Source: secondary_id

202103.

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Choroidal Thickness Vitrectomy
NCT02617147 COMPLETED
Macular Hole Reopening
NCT00927628 COMPLETED